TECH

Bio-Techne Corp

72.56

Oct 21 • 9:56 AM ET -0.03 (-0.03%)

Healthcare Biotechnology USA Large NASD

Peers: RVTY BIO TMO TXG DHR BRKR QGEN AVTR RGEN A

| Held by: VTI VOO VB RSP IVV VBK SPY FBT IBB XLV

Index	S&P 500
Market Cap	11.38B
Enterprise Value	11.40B
Income	181.86M
Sales	1.22B
Book/sh	13.51
Cash/sh	1.69
Dividend Est.	0.32 (0.44%)
Dividend TTM	0.32 (0.44%)
Dividend Ex-Date	Aug 24, 2026
Dividend Gr. 3/5Y	0.00% 0.00%
Payout	27.63%
Employees	3000
IPO	Feb 09, 1989

P/E	62.63
Forward P/E	30.53
PEG	3.83
P/S	9.36
P/B	5.37
P/C	42.98
P/FCF	43.23
EV/EBITDA	30.84
EV/Sales	9.38
Quick Ratio	3.35
Current Ratio	4.55
Debt/Eq	0.14
LT Debt/Eq	0.13
Option/Short	Yes / Yes

EPS (ttm)	1.16
EPS next Y	2.38
EPS next Q	0.44
EPS this Y	5.44%
EPS next Y	16.79%
EPS next 5Y	7.98%
EPS past 3/5Y	-13.05% 5.97%
Sales past 3/5Y	2.25% 5.47%
EPS Y/Y TTM	152.71%
Sales Y/Y TTM	-0.38%
EPS Q/Q	404.46%
Sales Q/Q	1.33%
Earnings	Aug 12 BMO
EPS/Sales Surpr.	0.12% 2.09%

Insider Own	0.55%
Insider Trans	-0.76%
Inst Own	113.44%
Inst Trans	-2.51%
ROA	6.95%
ROE	9.03%
ROIC	7.63%
Gross Margin	66.03%
Oper. Margin	22.42%
Profit Margin	14.97%
SMA20	0.07%
SMA50	0.21%
SMA200	15.31%
Trades

Shs Outstand	156.10M
Shs Float	155.95M
Short Float	4.74%
Short Ratio	2.45
Short Interest	7.39M
52W High	72.69 -0.19%
52W Low	43.19 67.97%
Volatility	0.14% 0.19%
ATR (14)	0.15
RSI (14)	56.48
Beta	1.29
Rel Volume	1.83
Avg Volume	3.02M
Volume	624,941

Perf Week	0.08%
Perf Month	0.01%
Perf Quarter	1.09%
Perf Half Y	23.86%
Perf YTD	23.37%
Perf Year	14.33%
Perf 3Y	13.24%
Perf 5Y	-41.66%
Perf 10Y	176.56%
Recom	3.00
Target Price	73.00
Prev Close	72.58
Price	72.56
Change %	-0.03%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$73
Jun-11-26	Initiated	Piper Sandler	Neutral	$65
May-15-26	Resumed	RBC Capital Mkts	Outperform	$62
Sep-03-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$73
Aug-21-25	Upgrade	Citigroup	Neutral → Buy	$70
Jul-22-25	Resumed	Stephens	Overweight	$65
Jul-09-25	Initiated	TD Cowen	Buy	$65
May-30-25	Initiated	Wells Fargo	Overweight	$59
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-18-25	Initiated	Evercore ISI	Outperform	$75
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$88 → $68
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89

Show Previous Ratings

Oct-09-26 06:41AM	Bio-Techne opens GMP small molecule facility in Bristol, UK (Pharmaceutical Business Review)
Oct-08-26 08:00AM	Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development (PR Newswire)
Sep-23-26 09:20AM	Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany (PR Newswire)
Sep-22-26 09:00AM	Bio-Techne Opens New Customer Experience Center in Dusseldorf to Accelerate Scientific Discovery and Customer Collaboration (PR Newswire)
Sep-09-26 03:24PM	Are FULC, WEAV, TECH Obtaining Fair Deals for their Shareholders? (PR Newswire)
06:30AM	Loading…
Sep-01-26 06:30AM	Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals (PR Newswire)
Aug-17-26 10:18PM	Are PAYO, TECH, CBAN Obtaining Fair Deals for their Shareholders? (PR Newswire)
Aug-13-26 06:30AM	Bio-Techne Corrects Dividend Announcement (PR Newswire)
Aug-12-26 06:30AM	Bio-Techne Releases Fourth Quarter Fiscal 2026 Results (PR Newswire)
06:30AM	Bio-Techne Declares Dividend (PR Newswire)
Jul-08-26 06:30AM	Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio (PR Newswire)
Jul-02-26 03:27PM	Are SYNA, IRDM, TECH, PATK Obtaining Fair Deals for their Shareholders? (PR Newswire)
Jul-01-26 05:41PM	SkylineDxs Merlin CP-GEP Granted FDA Breakthrough Device Designation (Exec Edge)
Jun-29-26 01:59PM	Are IRDM, TBPH, SYNA, TECH Obtaining Fair Deals for their Shareholders? (PR Newswire)
Jun-26-26 10:14AM	Germany's Merck KGaA is buying lab-tools supplier Bio-Techne for $11.3 billion (Quartz)
10:13AM	Loading…
10:13AM	Merck KGaA to acquire Bio-Techne in $11.3 billion deal (Quartz)
12:01AM	Germanys Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal (The Daily Upside)
Jun-25-26 04:30PM	Bio-Techne Corp. stock outperforms competitors on strong trading day (MarketWatch) +20.08%
01:53PM	Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? (PR Newswire)
12:09PM	Germany's Merck to Boost Lab-Tools Business With $11 Billion Bio-Techne Deal (The Wall Street Journal)
10:22AM	Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion (Medical Device Network)
07:18AM	Germany's Merck Is Buying Bio-Techne for $11.3 Billion (Barrons.com)
06:57AM	Germanys Merck to Acquire Bio-Techne in $11.3 Billion Deal (InvestorsHub)
06:10AM	Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets (PR Newswire)
05:57AM	Qualcomm stock surges on Meta deal, and other early market movers (MarketWatch)
Jun-11-26 09:38AM	SpaceX initiated, Intel upgraded: Wall Street's top analyst calls (The Fly)
Jun-04-26 06:30AM	Bio-Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization (PR Newswire)
May-13-26 04:30PM	Bio-Techne Corp. stock underperforms Wednesday when compared to competitors (MarketWatch) -5.34%
May-07-26 04:30PM	Bio-Techne Corp. stock outperforms competitors on strong trading day (MarketWatch) +7.39% -5.01%
May-06-26 04:57PM	Bio-Techne Corporation Q3 2026 Earnings Call Summary (Moby) -16.36%
06:30AM	Loading…
06:30AM	Bio-Techne Releases Third Quarter Fiscal 2026 Results (PR Newswire)
06:30AM	Bio-Techne Declares Dividend (PR Newswire)
May-04-26 07:00AM	Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference (PR Newswire)
Apr-16-26 08:00AM	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity (PR Newswire)
Apr-14-26 07:00AM	Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results (PR Newswire)
Mar-25-26 06:30AM	Bio-Techne Advances Spatial Biology with Modular Expansion of COMET Suite (PR Newswire)
Mar-18-26 06:18PM	Evolve Announces March 2026 Distributions for UltraYield ETFs and Certain Evolve Funds (TMX Newsfile)
Mar-06-26 02:01PM	Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know (StockStory)
11:30AM	Why Is Techne (TECH) Down 15.1% Since Last Earnings Report? (Zacks)
Mar-03-26 11:07PM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory)
Feb-24-26 02:28PM	Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections (Insider Monkey) +5.19%
07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Feb-17-26 11:40AM	KMDA or TECH: Which Is the Better Value Stock Right Now? (Zacks)
Feb-16-26 06:30AM	Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories (PR Newswire)
Feb-13-26 08:34PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Feb-11-26 12:04PM	What Are Wall Street Analysts' Target Price for Bio-Techne Stock? (Barchart)
09:00AM	Bio-Techne Announces Changes to its Leadership Team (PR Newswire)
12:36AM	5 Insightful Analyst Questions From Bio-Techne's Q4 Earnings Call (StockStory)
Feb-06-26 10:22AM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Feb-05-26 12:34AM	TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets (StockStory)
Feb-04-26 04:01PM	Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ... (GuruFocus.com) +6.25%
11:22AM	Bio-Techne Q2 Earnings Call Highlights (MarketBeat)
10:38AM	Bio-Techne (TECH) Q2 2026 Earnings Call Transcript (Motley Fool)
09:34AM	TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up (Zacks)
09:30AM	Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:40AM	Techne (TECH) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:37AM	Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales (StockStory)
06:30AM	Bio-Techne Releases Second Quarter Fiscal 2026 Results (PR Newswire)
06:30AM	Bio-Techne Declares Dividend (PR Newswire)
Feb-03-26 08:29AM	MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More (Zacks)
Feb-02-26 10:04PM	Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect (StockStory)
06:30AM	Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative (PR Newswire)
Jan-30-26 11:40AM	CSLLY or TECH: Which Is the Better Value Stock Right Now? (Zacks)
08:44AM	Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock? (Zacks)
Jan-28-26 06:30AM	Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers (PR Newswire)
Jan-20-26 07:00AM	Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results (PR Newswire)
Jan-12-26 06:49PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Jan-09-26 08:37AM	Here's What to Expect From Bio-Techne's Next Earnings Report (Barchart)
Jan-05-26 11:05PM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory) +5.67%
Jan-03-26 07:20AM	Klaviyo, Wingstop among Stephens Best Ideas for 2026 (TipRanks)
Dec-30-25 10:34PM	Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) (StockStory)
Dec-23-25 07:00AM	Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference (PR Newswire)
Dec-22-25 09:17AM	Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains? (Zacks)
Dec-16-25 07:40AM	Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector? (Barchart)
Dec-11-25 09:36AM	Here's Why BioTechne (TECH) Traded Lower in Q3 (Insider Monkey)
06:30AM	Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology (PR Newswire)
Dec-09-25 06:30AM	Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis (PR Newswire)
Dec-04-25 10:29AM	Bio-Techne Corporation (TECH): A Bull Case Theory (Insider Monkey)
Nov-25-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Nov-18-25 06:30AM	Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio (PR Newswire)
Nov-13-25 11:28PM	Bio-Techne Stock: Is Wall Street Bullish or Bearish? (Barchart)
09:01AM	Is Bio-Techne Corporation (TECH) a High-Quality Growth-Oriented Compounder Within The Healthcare Sector? (Insider Monkey)
Nov-11-25 03:55PM	Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know (StockStory)
Nov-07-25 05:36PM	McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. (Barrons.com)
Nov-06-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
Nov-05-25 09:57PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
04:03PM	Bio-Techne Corp (TECH) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
10:52AM	TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up (Zacks)
09:30AM	Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings (Zacks)
07:40AM	Techne (TECH) Meets Q1 Earnings Estimates (Zacks)
06:38AM	Bio-Techne (NASDAQ:TECH) Misses Q3 Revenue Estimates, Stock Drops (StockStory)
06:30AM	Bio-Techne Releases First Quarter Fiscal 2026 Results (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Nov-04-25 09:01AM	AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients (PR Newswire)
Nov-03-25 10:17PM	What To Expect From Bio-Techne's (TECH) Q3 Earnings (StockStory)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Sonoma Biotherapeutics (PR Newswire)
Oct-31-25 03:21PM	Why Bio-Techne (TECH) Stock Is Up Today (StockStory)
Oct-30-25 07:27PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Oct-29-25 10:00AM	Techne (TECH) Reports Next Week: What to Know Ahead of the Release (Zacks)
Oct-28-25 06:30AM	Bio-Techne Launches ProximityScope Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research (PR Newswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HIGGINS JOHN L	Director	Sep 28 '26	Option Exercise	0.00	15,940	0	82,816	Sep 30 04:13 PM
BAUMGARTNER ROBERT V	Director	Sep 22 '26	Option Exercise	0.00	15,940	0	62,443	Sep 24 04:52 PM
Kelderman Kim	Chief Executive Officer	Aug 15 '26	Option Exercise	0.00	21,470	0	93,583	Aug 18 05:14 PM
Hippel James	CFO	Aug 15 '26	Option Exercise	0.00	9,779	0	174,493	Aug 18 05:13 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Aug 15 '26	Option Exercise	0.00	6,416	0	26,919	Aug 18 05:13 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '26	Option Exercise	0.00	4,350	0	11,703	Aug 18 04:42 PM
Crouse Steven C.	President - Diag & Spatial Bi	Aug 15 '26	Option Exercise	0.00	5,423	0	12,184	Aug 18 04:13 PM
Herr Amy E.	Director	Aug 15 '26	Option Exercise	0.00	589	0	789	Aug 18 04:12 PM
Hippel James	CFO	Jul 29 '26	Option Exercise	47.60	62,068	2,954,437	215,738	Jul 31 05:18 PM
Kelderman Kim	Chief Executive Officer	Jul 28 '26	Option Exercise	47.60	35,000	1,666,000	100,799	Jul 30 04:11 PM
Bohnen Shane	SVP - General Counsel	Jul 23 '26	Option Exercise	47.60	448	21,325	7,697	Jul 27 04:03 PM
Herr Amy E.	Director	May 08 '26	Option Exercise	47.60	6,636	315,874	6,836	May 12 04:04 PM
Herr Amy E.	Director	May 08 '26	Sale	48.28	6,636	320,386	200	May 12 04:04 PM
JOSHUA MOLHO	Director	May 08 '26	Proposed Sale	48.28	6,636	320,417		May 08 04:23 PM
Hippel James	CFO	May 05 '26	Option Exercise	47.60	62,000	2,951,200	210,625	May 07 05:26 PM
Bohnen Shane	SVP - General Counsel	May 05 '26	Option Exercise	47.60	8,400	399,840	14,304	May 07 05:24 PM
Kelderman Kim	Chief Executive Officer	May 05 '26	Option Exercise	47.60	26,692	1,270,539	89,750	May 07 05:22 PM
Kelderman Kim	Chief Executive Officer	Apr 22 '26	Option Exercise	0.00	11,344	0	64,421	Apr 24 06:06 PM
Hippel James	CFO	Apr 22 '26	Option Exercise	0.00	62,000	0	204,722	Apr 24 06:05 PM
Kelderman Kim	Chief Executive Officer	Apr 14 '26	Option Exercise	0.00	36,500	0	85,165	Apr 16 04:19 PM
Bohnen Shane	SVP - General Counsel	Apr 03 '26	Option Exercise	0.00	2,259	0	6,644	Apr 07 04:59 PM
Herr Amy E.	Director	Feb 17 '26	Sale	59.10	1,976	116,791	200	Feb 19 04:57 PM
JOSHUA MOLHO	Director	Feb 17 '26	Proposed Sale	59.10	1,976	116,791		Feb 17 04:19 PM
Herr Amy E.	Director	Feb 03 '26	Option Exercise	0.00	38	0	2,192	Feb 05 06:30 PM
McManus Matthew	President - Diag & Spatial Bio	Feb 01 '26	Option Exercise	0.00	4,621	0	9,356	Feb 03 05:04 PM
Hippel James	CFO	Nov 03 '25	Option Exercise	0.00	24,704	0	154,587	Nov 05 04:46 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Nov 03 '25	Option Exercise	0.00	9,911	0	25,023	Nov 05 04:46 PM

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

CEOMr. Kim Kelderman

Executive VP of Finance & CFOMr. James T. Hippel CPA

Senior VPMr. Shane V. Bohnen

President of Protein Sciences SegmentMr. William A. Geist

VP & CTODr. Gary J. Latham Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TECH

Bio-Techne Corp

Upgrade your Finviz experience